Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:467 (1 March), doi:10.1136/bmj.39503.344826.DB
Ned Stafford
1 Hamburg
| The first 150 words of the full text of this article appear below. |
After more than three years of planning and study, the European Biobank was officially launched in February at a meeting in Cambridge. Its almost 100 funded participants outlined a strategy to have the legal framework and infrastructure in place by the middle of 2010.
Kurt Zatloukal, who is coordinating the preparations for what is officially called the European Biobanking and Biomolecular Resources Research Infrastructure, said that the European Union has allocated
5m (£3.8m; $7.4m) over the next 27 months for setting up the framework.
In an interview with the BMJ Dr Zatloukal, of the Institute of Pathology at the Medical University of Graz, Austria, said, "By 2011, I think a prototype of the biobank will be up and running."
But before that happens much work remains to be done to resolve key issues, he said, such as the location of the biobanks administrative headquarters and its non-profit legal form.
The
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?